Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Truyen

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of the Neurological Sciences|November 1, 1991
Long term follow-up of multiple sclerosis by standardized, non-contrast-enhanced magnetic resonance imagingL Truyen, J Gheuens, P M Parizel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 1996
Magnetic resonance imaging of epilepsy in multiple sclerosis: a case control study. Implications for treatment trials with 4-aminopyridineL Truyen, F Barkhof, S T Frequin, et al.
Magnetic Resonance Imaging|May 1, 1989
Improved sensitivity of MRI in multiple sclerosis by use of extensive standardized proceduresF L Van de Vyver, L Truyen, J Gheuens, et al.
Journal of the Neurological Sciences|May 1, 1990
Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging-protocolL Truyen, J Gheuens, F L Van de Vyver, et al.
The Journal of Prevention of Alzheimer'S Disease|November 30, 2017
Ethical Issues in the Development of Readiness Cohorts in Alzheimer's Disease ResearchR Milne, E Bunnik, K Tromp, et al.
Neurology|March 7, 2008
Safety and efficacy of galantamine in subjects with mild cognitive impairmentB Winblad, S Gauthier, L Scinto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1997
Risks of multiple sclerosis in relatives of patients in Flanders, BelgiumH Carton, R Vlietinck, J Debruyne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1997
Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trialsL Truyen, F Barkhof, M Tas, et al.
Neurology|December 1, 1996
Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosisL Truyen, J H van Waesberghe, M A van Walderveen, et al.
Magnetic Resonance Imaging|January 1, 1997
Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesionsJ H van Waesberghe, J A Castelijns, P Scheltens, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of the Neurological Sciences|November 1, 1991
Long term follow-up of multiple sclerosis by standardized, non-contrast-enhanced magnetic resonance imagingL Truyen, J Gheuens, P M Parizel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 1996
Magnetic resonance imaging of epilepsy in multiple sclerosis: a case control study. Implications for treatment trials with 4-aminopyridineL Truyen, F Barkhof, S T Frequin, et al.
Magnetic Resonance Imaging|May 1, 1989
Improved sensitivity of MRI in multiple sclerosis by use of extensive standardized proceduresF L Van de Vyver, L Truyen, J Gheuens, et al.
Journal of the Neurological Sciences|May 1, 1990
Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging-protocolL Truyen, J Gheuens, F L Van de Vyver, et al.
The Journal of Prevention of Alzheimer'S Disease|November 30, 2017
Ethical Issues in the Development of Readiness Cohorts in Alzheimer's Disease ResearchR Milne, E Bunnik, K Tromp, et al.
Neurology|March 7, 2008
Safety and efficacy of galantamine in subjects with mild cognitive impairmentB Winblad, S Gauthier, L Scinto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1997
Risks of multiple sclerosis in relatives of patients in Flanders, BelgiumH Carton, R Vlietinck, J Debruyne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1997
Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trialsL Truyen, F Barkhof, M Tas, et al.
Neurology|December 1, 1996
Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosisL Truyen, J H van Waesberghe, M A van Walderveen, et al.
Magnetic Resonance Imaging|January 1, 1997
Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesionsJ H van Waesberghe, J A Castelijns, P Scheltens, et al.
Pageof 3